Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03690154
Title Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Anti-tumor Activity of FN-1501 Monotherapy in Patients With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Shanghai Fosun Pharmaceutical Development Co, Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
KUMC Cancer Center Fairway Kansas 66205 United States Details
Karmanos Cancer Institute Detroit Michigan 48334 United States Details
Cabrini Malvern Hospital Malvern Victoria 3144 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field